Sujing Yuan

1.1k total citations · 2 hit papers
16 papers, 655 citations indexed

About

Sujing Yuan is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Sujing Yuan has authored 16 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 7 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Sujing Yuan's work include Immune Cell Function and Interaction (6 papers), Virus-based gene therapy research (5 papers) and Cancer Research and Treatments (4 papers). Sujing Yuan is often cited by papers focused on Immune Cell Function and Interaction (6 papers), Virus-based gene therapy research (5 papers) and Cancer Research and Treatments (4 papers). Sujing Yuan collaborates with scholars based in China, United States and United Kingdom. Sujing Yuan's co-authors include Liang Chu, Xinyuan Liu, Nicole M. Chapman, Hao Shi, Hongbo Chi, Seon Ah Lim, Jordy Saravia, Jianhua Chen, Sherri L. Rankin and Cliff Guy and has published in prestigious journals such as Nature, ACS Nano and Clinical Cancer Research.

In The Last Decade

Sujing Yuan

16 papers receiving 649 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity

2023 154 citations Chuansheng Guo, Zhiyuan You et al. Nature profile →
VDAC2 loss elicits tumour destruction and inflammation for cancer therapy

2025 17 citations Sujing Yuan, Renqiang Sun et al. Nature profile →

Peers

Countries citing papers authored by Sujing Yuan

Since Specialization

Citations

This map shows the geographic impact of Sujing Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sujing Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sujing Yuan more than expected).

Fields of papers citing papers by Sujing Yuan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sujing Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sujing Yuan. The network helps show where Sujing Yuan may publish in the future.

Co-authorship network of co-authors of Sujing Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Sujing Yuan. A scholar is included among the top collaborators of Sujing Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sujing Yuan. Sujing Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	VDAC2 loss elicits tumour destruction and inflammation for cancer therapy breakdown → 2025 ·Nature ·Sujing Yuan, Renqiang Sun, Hao Shi, Nicole M. Chapman, Haoran Hu, Cliff Guy, Sherri L. Rankin, Anil KC, (unknown), Xiaoxi Meng, (unknown), Peipei Zhou, (unknown), Stephen Gottschalk, Hongbo Chi	17
2	Vps34-orchestrated lipid signaling processes regulate the transitional heterogeneity and functional adaptation of effector regulatory T cells 2025 ·PLoS Biology ·(unknown), Nicole M. Chapman, Hao Shi, Xiaoxi Meng, Hongling Huang, Anil KC, Sherri L. Rankin, Jordy Saravia, Sujing Yuan, Haoran Hu, Peter Vogel, Hongbo Chi	5
3	SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity breakdown → 2023 ·Nature ·Chuansheng Guo, Zhiyuan You, Hao Shi, Yu Sun, Xingrong Du, Gustavo Palacios, Cliff Guy, Sujing Yuan, Nicole M. Chapman, Seon Ah Lim, (unknown), Jordy Saravia, Sherri L. Rankin, Yogesh Dhungana, Hongbo Chi	154
4	Single-cell CRISPR screens in vivo map T cell fate regulomes in cancer 2023 ·Nature ·Peipei Zhou, Hao Shi, Hongling Huang, (unknown), Sujing Yuan, Nicole M. Chapman, Jon P. Connelly, Seon Ah Lim, Jordy Saravia, Anil KC, Shondra M. Pruett‐Miller, Hongbo Chi	76
5	Epigenetic drug screen identified IOX1 as an inhibitor of Th17-mediated inflammation through targeting TET2 2022 ·EBioMedicine ·Xiao Hu, Yanli Zou, David A. Copland, (unknown), Yan Li, Philippa Lait, (unknown), Zhihui Zhang, Shixin Guo, Juanran Liang, Tingting Chen, Jing Jing Li, Sujing Yuan, Shuo Li, Penghui Zhou, Yizhi Liu, Andrew D. Dick, Xiaofeng Wen, Richard Lee, Lai Wei	8
6	DGKA Mediates Resistance to PD-1 Blockade 2021 ·Cancer Immunology Research ·Lingyi Fu, Sen Li, Weiwei Xiao, Kuai Yu, Shuo Li, Sujing Yuan, Jianfei Shen, (unknown), (unknown), Jianeng Zhang, Siyu Chen, Wende Li, Hua You, Xiaojun Xia, Tiebang Kang, Jing Tan, Gong Chen, Ankui Yang, Yuanhong Gao, Penghui Zhou	23
7	Carfilzomib modulates tumor microenvironment to potentiate immune checkpoint therapy for cancer 2021 ·EMBO Molecular Medicine ·Qian Zhou, (unknown), Tong Yang, Jin Liu, Bo Li, Yingchang Li, Zhenzhen Fan, Weida Wang, Wensheng Chen, Sujing Yuan, Meng Xu, (unknown), Zhidong Luan, Zhongjun Xia, Penghui Zhou, Yadong Huang, Liang Chen	42
8	Structure-affinity relationship of the binding of phenolic acids and their derivatives to bovine serum albumin 2018 ·Food Chemistry ·Sujing Yuan, (unknown), Jiaxin Liu, Yu Zhao, Libo Tan, Jingwen Liu, Qingyu Wang, Hao Zhang	23
9	RGD-modified oncolytic adenovirus-harboring shPKM2 exhibits a potent cytotoxic effect in pancreatic cancer via autophagy inhibition and apoptosis promotion 2017 ·Cell Death and Disease ·(unknown), Liang Chu, Sujing Yuan, Yuanqin Yang, Yang Yu, (unknown), Kangjian Zhang, Xinyuan Liu, (unknown), Ling Fang, Zhi‐Nan Chen, (unknown)	27
10	An Oncolytic Adenovirus Expressing SNORD44 and GAS5 Exhibits Antitumor Effect in Colorectal Cancer Cells 2017 ·Human Gene Therapy ·Sujing Yuan, Yu Wu, Yigang Wang, Jianhua Chen, Liang Chu	31
11	A Potent In Vivo Antitumor Efficacy of Novel Recombinant Type I Interferon 2016 ·Clinical Cancer Research ·(unknown), (unknown), Yuanqin Yang, Huiling Li, (unknown), (unknown), Xijun Liu, Sujing Yuan, Xian-Long Fang, Jing Xiao, Shuai Wu, Haineng Xu, Liang Chu, Kanstantsin V. Katlinski, Yuliya V. Katlinskaya, (unknown), (unknown), Dacheng Wang, Xinyuan Liu, Serge Y. Fuchs	14
12	Oncolytic vaccine virus harbouring the IL-24 gene suppresses the growth of lung cancer by inducing apoptosis 2016 ·Biochemical and Biophysical Research Communications ·(unknown), (unknown), Yupei Liang, Jinqing Hu, Sujing Yuan	28
13	SNORD126 promotes HCC and CRC cell growth by activating the PI3K–AKT pathway through FGFR2 2016 ·Journal of Molecular Cell Biology ·Xian-Long Fang, Dongmei Yang, Hongping Luo, Shuai Wu, Wenjie Dong, (unknown), Sujing Yuan, (unknown), (unknown), Xinyuan Liu, Liang Chu	81
14	An oncolytic adenovirus that expresses the HAb18 and interleukin 24 genes exhibits enhanced antitumor activity in hepatocellular carcinoma cells 2016 ·Oncotarget ·Sujing Yuan, Xian-Long Fang, (unknown), (unknown), Xinyuan Liu, Liang Chu	14
15	Oncolytic Adenovirus Complexes Coated with Lipids and Calcium Phosphate for Cancer Gene Therapy 2016 ·ACS Nano ·Jianhua Chen, (unknown), Sujing Yuan, Rongxin Li, (unknown), Liang Chu, Li Ding, Ying Sun, Xinyuan Liu, Yourong Duan	102
16	A Damage Prognosis Method of Girder Structures Based on Wavelet Neural Networks 2014 ·Mathematical Problems in Engineering ·(unknown), Zhouhong Zong, (unknown), Sujing Yuan	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact